News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
514,194 Results
Type
Article (38002)
Company Profile (344)
Press Release (475840)
Multimedia
Podcasts (106)
Webinars (15)
Section
Business (142566)
Career Advice (1399)
Deals (27707)
Drug Delivery (114)
Drug Development (73378)
Employer Resources (117)
FDA (11807)
Job Trends (10529)
News (259633)
Policy (27993)
Tag
Academia (2138)
Accelerated approval (27)
Adcomms (30)
Allergies (119)
Alliances (45857)
ALS (148)
Alzheimer's disease (1577)
Antibody-drug conjugate (ADC) (278)
Approvals (11952)
Artificial intelligence (389)
Autoimmune disease (117)
Automation (21)
Bankruptcy (266)
Best Places to Work (8794)
BIOSECURE Act (17)
Biosimilars (162)
Biotechnology (252)
Bladder cancer (134)
Brain cancer (58)
Breast cancer (511)
Cancer (4091)
Cardiovascular disease (334)
Career advice (1193)
Career pathing (25)
CAR-T (258)
CDC (54)
Cell therapy (667)
Cervical cancer (33)
Clinical research (61955)
Collaboration (1435)
Company closure (3)
Compensation (984)
Complete response letters (56)
COVID-19 (2687)
CRISPR (86)
C-suite (583)
Cystic fibrosis (135)
Data (5297)
Decentralized trials (1)
Denatured (19)
Depression (109)
Diabetes (425)
Diagnostics (4271)
Digital health (22)
Diversity (7)
Diversity, equity & inclusion (37)
Drug discovery (214)
Drug pricing (176)
Drug shortages (32)
Duchenne muscular dystrophy (220)
Earnings (54094)
Editorial (54)
Employer branding (14)
Employer resources (110)
Events (75146)
Executive appointments (739)
FDA (14251)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (20)
Funding (1189)
Gene editing (185)
Generative AI (33)
Gene therapy (554)
GLP-1 (951)
Government (4516)
Grass and pollen (6)
Guidances (318)
Healthcare (13702)
HIV (49)
Huntington's disease (43)
IgA nephropathy (73)
Immunology and inflammation (237)
Immuno-oncology (37)
Indications (69)
Infectious disease (2946)
Inflammatory bowel disease (171)
Inflation Reduction Act (14)
Influenza (107)
Intellectual property (192)
Interviews (242)
IPO (12798)
IRA (51)
Job creations (2115)
Job search strategy (1009)
Kidney cancer (12)
Labor market (51)
Layoffs (439)
Leadership (24)
Legal (7326)
Liver cancer (73)
Longevity (12)
Lung cancer (567)
Lymphoma (329)
Machine learning (38)
Management (36)
Manufacturing (590)
MASH (162)
Medical device (7447)
Medtech (7474)
Mergers & acquisitions (15796)
Metabolic disorders (1145)
Multiple sclerosis (134)
NASH (22)
Neurodegenerative disease (272)
Neuropsychiatric disorders (76)
Neuroscience (2641)
NextGen: Class of 2025 (4532)
Non-profit (3127)
Now hiring (31)
Obesity (560)
Opinion (260)
Ovarian cancer (142)
Pain (143)
Pancreatic cancer (183)
Parkinson's disease (248)
Partnered (25)
Patents (393)
Patient recruitment (357)
Peanut (53)
People (39493)
Pharmaceutical (58)
Pharmacy benefit managers (21)
Phase I (19740)
Phase II (27423)
Phase III (20373)
Pipeline (3604)
Policy (277)
Postmarket research (2035)
Preclinical (8460)
Press Release (44)
Prostate cancer (203)
Psychedelics (50)
Radiopharmaceuticals (275)
Rare diseases (740)
Real estate (3308)
Recruiting (52)
Regulatory (19903)
Reports (29)
Research institute (1957)
Resumes & cover letters (207)
Rett syndrome (24)
RNA editing (16)
RSV (78)
Schizophrenia (139)
Series A (198)
Series B (146)
Service/supplier (4)
Sickle cell disease (94)
Special edition (19)
Spinal muscular atrophy (155)
Sponsored (31)
Startups (2765)
State (1)
Stomach cancer (13)
Supply chain (86)
Tariffs (73)
The Weekly (86)
Vaccines (1040)
Venture capital (74)
Weight loss (377)
Women's health (50)
Worklife (12)
Date
Today (9)
Last 7 days (195)
Last 30 days (1795)
Last 365 days (26002)
2025 (25926)
2024 (29544)
2023 (32866)
2022 (42105)
2021 (45098)
2020 (41715)
2019 (33750)
2018 (25326)
2017 (24806)
2016 (23021)
2015 (26825)
2014 (20473)
2013 (16335)
2012 (17008)
2011 (17646)
2010 (16406)
Location
Africa (618)
Alabama (72)
Alaska (5)
Arizona (156)
Arkansas (8)
Asia (32096)
Australia (5672)
California (8757)
Canada (2560)
China (920)
Colorado (331)
Connecticut (364)
Delaware (288)
Europe (75313)
Florida (1223)
Georgia (285)
Hawaii (3)
Idaho (39)
Illinois (597)
India (51)
Indiana (367)
Iowa (19)
Japan (348)
Kansas (98)
Kentucky (26)
Louisiana (20)
Maine (37)
Maryland (1136)
Massachusetts (6612)
Michigan (182)
Minnesota (373)
Mississippi (3)
Missouri (85)
Montana (26)
Nebraska (12)
Nevada (87)
New Hampshire (35)
New Jersey (2455)
New Mexico (19)
New York (2327)
North Carolina (1097)
North Dakota (7)
Northern California (4235)
Ohio (232)
Oklahoma (14)
Oregon (26)
Pennsylvania (1685)
Puerto Rico (14)
Rhode Island (30)
South America (851)
South Carolina (33)
South Dakota (1)
Southern California (3418)
Tennessee (94)
Texas (1208)
United States (30637)
Utah (188)
Vermont (1)
Virginia (208)
Washington D.C. (55)
Washington State (689)
West Virginia (3)
Wisconsin (68)
Wyoming (2)
514,194 Results for "affimed therapeutics ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Memo Therapeutics AG’s Potravitug Granted Orphan Designation in the European Union
December 18, 2025
·
3 min read
Press Releases
Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases
November 13, 2025
·
10 min read
Startups
Six Startups Changing The Way We Age
Armed with the latest biological knowledge and cutting-edge computational techniques—and, of course, investor dollars—these six biotechs are playing in the largely underappreciated longevity space, developing therapies that may improve the quality of aging.
July 9, 2025
·
11 min read
·
Tristan Manalac
Startups
Longevity Biotechs Strive for Better Aging—Not Just Life Extension
The industry sector focused on aging is only about 10 years old, but acting on what scientists already know, a new crop of biotechs, backed by investors, are taking a disease-centric approach to extending the human lifespan.
July 9, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Dupixent® (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma
December 23, 2025
·
23 min read
Artificial intelligence
Roche’s Chugai Breaks Into Aging via Potential $1B+ Deal With AI Outfit Gero
The partnership will give Chugai access to Gero’s artificial intelligence technology to discover novel targets in aging-related diseases. Chugai will then develop antibody-based drugs based on the findings.
July 7, 2025
·
2 min read
·
Dan Samorodnitsky
Collaboration
Alphabet Subsidiary Calico Colors In Up To $570M+ Aging Deal With China’s Mabwell
Calico will leverage 9MW3811’s anti-inflammatory mechanism to advance its mission of addressing aging-related diseases.
June 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Cirrus Therapeutics Raises $11 M Seed Financing to Advance Novel Ocular Gene Therapy to Reverse Underlying Age-Related Cause of Dry AMD
October 3, 2025
·
5 min read
Press Releases
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
December 23, 2025
·
14 min read
Press Releases
Opterion Health AG Announces Appointment of Andreas Schuh as Chief Financial Officer
December 1, 2025
·
2 min read
1 of 51,420
Next
